Status:
COMPLETED
School Based Malaria Control in Ugandan Schoolchildren
Lead Sponsor:
Makerere University
Collaborating Sponsors:
Bill and Melinda Gates Foundation
Conditions:
Malaria
Eligibility:
All Genders
6-14 years
Phase:
PHASE3
Brief Summary
The investigators hypothesize that schoolchildren treated with IPT using DP over one year of follow-up will have a different risk of clinical malaria compared to those treated with placebo.
Eligibility Criteria
Inclusion
- Age ≥ 6 - 14 years
- Pupils enrolled at participating school
- Willingness of the parent/guardian to provide consent
- Provision of assent by pupil (those above 8 years)
Exclusion
- Known allergy or history of adverse reaction to study medications
- Intention of changing of schools during the follow-up period
- History (obtained from the parent/guardian) of any known serious chronic disease requiring frequent medical care
Key Trial Info
Start Date :
February 1 2011
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
September 1 2012
Estimated Enrollment :
740 Patients enrolled
Trial Details
Trial ID
NCT01231880
Start Date
February 1 2011
End Date
September 1 2012
Last Update
May 23 2013
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Mulanda Sub-district
Tororo, Uganda, Uganda, 256